SCVD Faculty

David Beasley, PhD

Dr. Beasley's research focuses on the plasticity of flavivirus envelope protein sequences and the molecular basis of virulence and antigenic variations between strains of West Nile virus and other mosquito-borne flaviviruses, with the goal of developing and evaluating new and improved vaccines, diagnostics and therapeutics. He is Co-Director of UTMB's select agent BSL3 laboratories and Director of the Galveston National Laboratory Regulatory Compliance Core and has been actively involved in UTMB's preparations for conduct of GLP compliant preclinical studies, with an emphasis on development and use of animal models for product testing under the Animal Rule.

Search PubMed for Dr. Beasley's publications.